Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
Apraglutide is a synthetic peptide analog of glucagon-like peptide-2 (GLP-2), designed to mimic the endogenous hormone's physiological functions and enhance its stability for research applications. As a member of the GLP-2 analog family, apraglutide exhibits potent intestinotrophic activity, making it highly relevant for investigations into gastrointestinal biology, epithelial regeneration, and peptide-receptor interactions. Its engineered modifications confer increased resistance to enzymatic degradation, enabling more sustained biological activity in experimental systems. The compound is widely utilized in preclinical research settings to elucidate the molecular mechanisms underlying mucosal growth, nutrient absorption, and gastrointestinal adaptation.
Receptor pharmacology: Apraglutide serves as a valuable tool for studying the pharmacodynamics and pharmacokinetics of GLP-2 receptor agonists. By selectively binding to the GLP-2 receptor, it facilitates detailed characterization of receptor-ligand interactions, downstream signaling pathways, and receptor activation profiles. Researchers employ this peptide to dissect the structure-activity relationships critical for receptor specificity and to compare the efficacy of novel analogs in cell-based assays and animal models.
Intestinal physiology research: The compound is extensively used to investigate the regulation of intestinal growth, repair, and function. Its intestinotrophic effects provide a robust model for probing the cellular and molecular mechanisms that govern epithelial proliferation, crypt-villus architecture, and mucosal barrier integrity. Experimental protocols leveraging apraglutide enable the assessment of nutrient absorption, fluid balance, and tissue remodeling in both in vitro and in vivo systems, supporting advances in gastrointestinal biology and nutrient transport studies.
Peptide stability and metabolic studies: Owing to its enhanced resistance to dipeptidyl peptidase-IV (DPP-IV) and other proteolytic enzymes, apraglutide is frequently utilized in studies focused on peptide stability, degradation kinetics, and metabolic fate. Its structural modifications offer a platform for examining how specific amino acid substitutions influence peptide half-life, bioavailability, and systemic exposure. Such research is instrumental for the rational design of next-generation peptide therapeutics and for understanding the pharmacological optimization of peptide drugs.
Peptide synthesis and analytical method development: Apraglutide's well-defined sequence and tailored modifications make it a reference standard in peptide synthesis and analytical chemistry. It is used to validate synthetic protocols, optimize purification strategies, and calibrate analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. These applications are essential for ensuring the reproducibility and quality control of peptide-based research reagents.
Cell signaling and gene expression analysis: The peptide analog is also applied in studies exploring the downstream effects of GLP-2 receptor activation on cellular signaling cascades and gene expression profiles. By modulating pathways involved in cell proliferation, anti-apoptotic responses, and inflammation, apraglutide enables researchers to delineate the transcriptional and post-transcriptional events associated with GLP-2 signaling. These insights contribute to a deeper understanding of gastrointestinal tissue homeostasis and adaptive responses under various physiological and experimental conditions.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More